Skip to content

Onconetix, Inc.: 10-Q filed 2025-11-13

What Onconetix, Inc. reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 47 published measures, 136 facts as tagged in accession 0001213900-25-110142.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-13
Fiscal period
fiscal Q3 2025
Accession
0001213900-25-110142 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Onconetix, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-3019,678,868USD
At 2024-12-3128,181,563USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3016,303,023USD
At 2024-12-3118,571,008USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-8,783,702USD92
2025-01-01 to 2025-09-30-19,702,029USD273
2025-04-01 to 2025-06-30-2,372,442USD91
2025-01-01 to 2025-03-31-8,545,885USD90
2024-07-01 to 2024-09-30-3,827,405USD92
2024-01-01 to 2024-09-30-29,252,681USD274
2024-04-01 to 2024-06-30-14,306,704USD91
2024-01-01 to 2024-03-31-11,118,572USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-6,587,805USD273
2024-01-01 to 2024-09-30-9,578,169USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-09-3024,597USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-07-01 to 2025-09-30303,651USD92
2025-01-01 to 2025-09-30511,775USD273
2024-07-01 to 2024-09-30406,859USD92
2024-01-01 to 2024-09-301,812,140USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-307,905,978USD273
2024-01-01 to 2024-09-305,440,310USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-24,597USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-136,884,245USD
At 2024-12-31-115,683,621USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,405,469shares92
2025-01-01 to 2025-09-30727,431shares273
2024-07-01 to 2024-09-3015,366shares92
2024-01-01 to 2024-09-309,491shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,405,469shares92
2025-01-01 to 2025-09-30727,431shares273
2024-07-01 to 2024-09-3015,366shares92
2024-01-01 to 2024-09-309,491shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-6.25USD/shares92
2025-01-01 to 2025-09-30-29.14USD/shares273
2024-07-01 to 2024-09-30-249.08USD/shares92
2024-01-01 to 2024-09-30-3,082.12USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-6.25USD/shares92
2025-01-01 to 2025-09-30-29.14USD/shares273
2024-07-01 to 2024-09-30-249.08USD/shares92
2024-01-01 to 2024-09-30-3,082.12USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-56,384USD92
2024-01-01 to 2024-09-30-127,183USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-3040,388USD
At 2024-12-3162,896USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-09-3070,033USD273
2024-01-01 to 2024-09-3098,228USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,069,242USD92
2025-01-01 to 2025-09-30-16,575,489USD273
2024-07-01 to 2024-09-30-2,645,867USD92
2024-01-01 to 2024-09-30-27,342,877USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-301,302,026USD
At 2024-12-31950,267USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3016,303,023USD
At 2024-12-3118,290,129USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-301,804,163USD
At 2024-12-313,787,564USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-09-3018,180,299USD
At 2024-12-3127,048,973USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-302,552USD
At 2024-12-3125,717USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,338,136USD92
2025-01-01 to 2025-09-3016,960,718USD273
2024-07-01 to 2024-09-302,751,281USD92
2024-01-01 to 2024-09-3027,738,007USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-30151,556USD
At 2024-12-3164,079USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30268,894USD92
2025-01-01 to 2025-09-30385,229USD273
2024-07-01 to 2024-09-30105,414USD92
2024-01-01 to 2024-09-30395,130USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-3034,757USD92
2025-01-01 to 2025-09-30126,546USD273
2024-07-01 to 2024-09-30301,445USD92
2024-01-01 to 2024-09-301,417,010USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-302,341,347USD92
2025-01-01 to 2025-09-305,539,144USD273
2024-07-01 to 2024-09-302,641,916USD92
2024-01-01 to 2024-09-308,599,642USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-301,560,668shares
At 2024-12-31138,270shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-30836,556USD
At 2024-12-31646,500USD
At 2024-09-30341,495USD
At 2023-12-314,554,335USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-09-30141,431,240USD
At 2024-12-31127,825,743USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-09-30-547,098USD
At 2024-12-31-2,723,397USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-09-303,374,121USD
At 2025-06-305,909,761USD
At 2025-03-313,992,793USD
At 2024-12-318,542,627USD
At 2024-09-3041,022,620USD
At 2024-06-30-28,728,634USD
At 2024-03-31-14,497,912USD
At 2023-12-311,404,476USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-306,155USD
At 2024-12-31119,427USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-30476,289USD
At 2024-12-31888,988USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-09-30311,362USD
At 2024-12-31213,971USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-8,783,702USD92
2025-01-01 to 2025-09-30-19,702,029USD273
2024-07-01 to 2024-09-30-3,883,789USD92
2024-01-01 to 2024-09-30-29,379,864USD274

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-8,945,454USD92
2025-01-01 to 2025-09-30-17,525,730USD273
2024-07-01 to 2024-09-30-435,896USD92
2024-01-01 to 2024-09-30-30,621,044USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-8,783,702USD92
2025-01-01 to 2025-09-30-21,200,624USD273
2024-07-01 to 2024-09-30-3,827,405USD92
2024-01-01 to 2024-09-30-29,252,681USD274

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-07-01 to 2025-09-30300,069USD92
2025-01-01 to 2025-09-30746,758USD273
2024-07-01 to 2024-09-30231,656USD92
2024-01-01 to 2024-09-30625,084USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-8,063USD92
2025-01-01 to 2025-09-30-36,086USD273
2024-07-01 to 2024-09-3044,988USD92
2024-01-01 to 2024-09-3041,894USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-6,714,460USD92
2025-01-01 to 2025-09-30-3,126,540USD273
2024-07-01 to 2024-09-30-1,237,922USD92
2024-01-01 to 2024-09-30-2,036,987USD274

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2024-07-01 to 2024-09-3056,000USD92
2024-01-01 to 2024-09-30127,000USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-127,183USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-09-306,391,634USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-25,244USD273
2024-01-01 to 2024-09-30-49,079USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-3074,182USD273
2024-01-01 to 2024-09-30113,102USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-1,047,968USD273
2024-01-01 to 2024-09-30-1,242,071USD274

Inspect the source

Entity
Onconetix, Inc. / CIK 0001782107
Captured
2026-09-21T17:31:07.815Z
SEC response SHA-256
8853d40ab3bc9b0b28d644990b0d8b93bfdb4ec13654d313eee955e0eae089fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001782107.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))